Pfizer slashes earnings forecast on decrease COVID gross sales, will lower prices
A corporate brand is noticed at a Pfizer administrative center in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/Record Photograph Achieve Licensing RightsOct 13 (Reuters) – Pfizer (PFE.N) on Friday slashed its full-year
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/adn/IYJE74TDND23IDGOSZ25YFQVQQ.jpg "An Idaho well being division isn’t allowed to present COVID-19 vaccines anymore. Professionals say it’s a primary.")
